SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-022347
Filing Date
2017-11-07
Accepted
2017-11-07 17:26:25
Documents
62
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q acor-10q_20170930.htm 10-Q 1364876
2 EX-10.1 acor-ex101_53.htm EX-10.1 105142
3 EX-31.1 acor-ex311_7.htm EX-31.1 16243
4 EX-31.2 acor-ex312_8.htm EX-31.2 15768
5 EX-32.1 acor-ex321_9.htm EX-32.1 6695
6 EX-32.2 acor-ex322_10.htm EX-32.2 6915
7 GRAPHIC g20171107221016375755.jpg GRAPHIC 53446
  Complete submission text file 0001564590-17-022347.txt   5611311

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT acor-20170930.xml EX-101.INS 1161030
9 XBRL TAXONOMY EXTENSION SCHEMA acor-20170930.xsd EX-101.SCH 34124
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acor-20170930_cal.xml EX-101.CAL 60001
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acor-20170930_def.xml EX-101.DEF 120049
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE acor-20170930_lab.xml EX-101.LAB 355804
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acor-20170930_pre.xml EX-101.PRE 268481
Mailing Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31938 | Film No.: 171184481
SIC: 2836 Biological Products, (No Diagnostic Substances)